Middle East and Africa CPAP Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Middle East and Africa CPAP Devices Market Size

• The Middle East and Africa CPAP Devices market size was valued at USD 138.65 million in 2024 and is expected to reach USD 216.04 million by 2032, at a CAGR of 5.70% during the forecast period
• The market growth is largely fueled by the increasing prevalence of obstructive sleep apnea (OSA) and rising awareness regarding sleep-related disorders across the region, leading to a surge in diagnosis and treatment adoption
• Furthermore, improving healthcare infrastructure, growing penetration of private healthcare providers, and the rising availability of technologically advanced CPAP devices are accelerating the demand. These combined factors are significantly driving the market expansion across the Middle East and Africa

Middle East and Africa CPAP Devices Market Analysis

• CPAP devices, which deliver continuous positive airway pressure to maintain open airways during sleep, are becoming increasingly essential in managing obstructive sleep apnea (OSA) across the Middle East and Africa due to rising awareness, expanding diagnostic capabilities, and the growing burden of sleep-related disorders in both public and private healthcare sectors
• The escalating demand for CPAP devices is primarily fueled by increasing obesity rates, a growing aging population, and rising adoption of home-based respiratory care solutions, alongside enhanced availability of portable and user-friendly devices
• South Africa dominated the CPAP devices market with the largest revenue share of 31.9% in 2024, supported by well-established healthcare infrastructure, active sleep disorder awareness campaigns, and growing treatment accessibility in urban centers
• The UAE is expected to be the fastest growing country in the CPAP devices market during the forecast period due to increasing medical tourism, healthcare digitization, and growing investments in specialized respiratory care services
• The CPAP Devices segment dominated the CPAP devices market by product type with a share of 67.2% in 2024, driven by increased diagnosis rates and the expanding availability of technologically advanced therapy units across healthcare settings and homecare environments

Report Scope and Middle East and Africa CPAP Devices Market Segmentation       

Middle East and Africa CPAP Devices Market Trends

“Rising Demand for Portable and Smart CPAP Devices”

• A significant and accelerating trend in the Middle East and Africa CPAP devices market is the growing preference for compact, portable, and technologically advanced CPAP solutions that cater to both clinical and homecare settings, especially in urban regions with improving healthcare access and increasing awareness of sleep apnea
  • For instance, Philips’ DreamStation Go and ResMed’s AirMini have gained traction in the region for their lightweight designs and integrated smart features such as Bluetooth connectivity, app-based monitoring, and cloud data sharing with physicians, enabling more personalized and convenient therapy management
• These smart CPAP devices allow patients to track their sleep patterns, receive real-time feedback, and share compliance reports with healthcare providers remotely, significantly enhancing adherence to treatment plans
• Moreover, innovations such as automatic pressure adjustment and humidification systems further improve user comfort, while cloud-connected platforms such as ResMed’s myAir offer coaching and support to improve therapy outcomes
• This shift toward portability and smart functionality is being driven by a growing working population, increased travel, and rising demand for home-based healthcare across countries such as South Africa, UAE, and Saudi Arabia
• The demand for smart, portable CPAP devices is rising rapidly as patients seek comfort, mobility, and integration with broader digital health ecosystems, transforming sleep apnea treatment into a more user-centric and data-driven experience

Middle East and Africa CPAP Devices Market Dynamics

Driver

“Growing Sleep Apnea Awareness and Expansion of Home Healthcare”

• The increasing prevalence of obstructive sleep apnea, alongside rising awareness of its health impacts, is a major driver of the CPAP devices market across the Middle East and Africa. Campaigns led by healthcare organizations and private providers are encouraging diagnosis and early intervention, especially in high-risk groups such as the elderly and obese
  • For instance, initiatives in South Africa and the UAE to screen for sleep disorders in primary care settings are driving early diagnosis rates, thereby fueling demand for therapeutic devices such as CPAP machines
• In addition, the expansion of home healthcare services is creating opportunities for non-invasive sleep therapy solutions, supported by portable CPAP systems and remote monitoring platforms
• As public and private healthcare investments grow in the region, particularly in urban centers, the availability and affordability of CPAP devices are improving, further driving market growth
• The convenience of home-based therapy and rising preference for non-hospital treatment options are accelerating the adoption of CPAP devices in both high-income and emerging economies within the region

Restraint/Challenge

“Limited Awareness and Affordability Issues in Underserved Regions”

• Despite growing adoption in urban areas, limited awareness about sleep apnea and its risks remains a significant barrier in rural and underserved parts of the Middle East and Africa
• Many individuals remain undiagnosed due to lack of specialist services, sleep labs, and public knowledge about treatment options such as CPAP therapy
• Moreover, the relatively high upfront cost of CPAP devices and ongoing expenses for consumables such as masks and filters can be prohibitive for price-sensitive populations. In regions where reimbursement or insurance coverage is limited, affordability becomes a major hurdle to widespread adoption
  • For instance, while premium brands such as ResMed and Philips dominate urban markets, there is still a shortage of cost-effective alternatives for broader accessibility
• Bridging these gaps through government-supported awareness campaigns, public-private partnerships, and the introduction of low-cost CPAP options tailored for the African and Middle Eastern markets will be essential for long-term market expansion

Middle East and Africa CPAP Devices Market Scope

The market is segmented on the basis of product type, modality, and end user.

• By Product Type

On the basis of product type, the Middle East and Africa CPAP devices market is segmented into CPAP devices and consumables. The CPAP Devices segment dominated the market with the largest revenue share of 67.2% in 2024, driven by the increasing prevalence of obstructive sleep apnea (OSA), advancements in device technology, and growing awareness of sleep therapy. CPAP machines are the primary line of treatment for moderate to severe OSA, and their rising adoption is supported by growing diagnosis rates and an expanding number of sleep clinics across the region.

The Consumables segment, including masks, tubing, filters, and humidifiers, is expected to witness the fastest growth from 2025 to 2032 due to the recurring need for replacements and hygiene maintenance. As the installed base of CPAP devices grows, the demand for associated consumables will rise steadily, supported by an increased focus on user comfort and compliance.

• By Modality

On the basis of modality, the CPAP devices market is categorized into standalone and portable CPAP devices. The Portable CPAP Devices segment held the largest revenue share of 58.6% in 2024, driven by the rising preference for home-based therapy, the convenience of travel-friendly devices, and increasing demand among working professionals and frequent travelers. Portable models such as ResMed AirMini and Philips DreamStation Go are gaining popularity for their compact size, smart connectivity features, and ease of use.

The Standalone CPAP Devices segment, dominant in clinical settings, is expected to witness moderate growth during forecast period, primarily driven by hospitals and sleep labs. These devices are generally bulkier and provide advanced diagnostic capabilities but are less favored for personal use compared to their portable counterparts.

• By End User

On the basis of end user, the CPAP devices market is segmented into home care, hospitals, private clinics, and others. The Home Care segment led the market with the largest revenue share of 46.9% in 2024, owing to a strong shift toward at-home sleep apnea treatment, cost-effectiveness, and the availability of compact, easy-to-use CPAP devices suitable for personal use. Increased awareness, support programs for therapy adherence, and mobile app integration are further boosting patient preference for home-based solutions.

The Hospitals segment is expected to witness fastest growth during forecast period, due to the need for acute care and professional diagnosis in severe OSA cases, while Private Clinics are increasingly adopting CPAP therapy services to cater to growing outpatient demand. The Others category, including sleep labs and rehabilitation centers, also represents a growing end-user group as awareness and diagnosis improve across the region.

Middle East and Africa CPAP Devices Market Regional Analysis

• South Africa dominated the CPAP devices market with the largest revenue share of 31.9% in 2024, supported by well-established healthcare infrastructure, active sleep disorder awareness campaigns, and growing treatment accessibility in urban centers
• Consumers in the region are increasingly recognizing the importance of early diagnosis and continuous treatment of obstructive sleep apnea, with a notable shift toward home-based care and portable CPAP device usage
• This adoption is further supported by improving access to respiratory care, rising obesity rates, and the presence of international healthcare providers, positioning South Africa as a regional leader in the adoption of CPAP therapy across both clinical and personal health settings

The South Africa CPAP Devices Market Insight

The South Africa CPAP devices market captured the largest revenue share of 31.4% in 2024 within the Middle East and Africa, driven by high awareness of sleep disorders, access to diagnostic facilities, and robust public-private partnerships in healthcare. The country’s growing geriatric population and rising prevalence of obesity are further fueling the need for effective sleep apnea treatment. In addition, a shift toward homecare solutions and rising consumer interest in digital health platforms are supporting the growth of smart and portable CPAP devices in the market.

Saudi Arabia CPAP Devices Market Insight

The Saudi Arabia CPAP devices market is projected to grow at a strong CAGR during the forecast period, propelled by the government's Vision 2030 healthcare initiatives and growing emphasis on improving the quality of life. Rising prevalence of chronic conditions such as diabetes and obesity, along with increasing investments in hospital infrastructure and sleep clinics, is creating favorable conditions for CPAP device adoption. The expanding private healthcare sector and increasing use of telehealth for follow-up care also support market growth.

UAE CPAP Devices Market Insight

The UAE CPAP devices market is anticipated to grow at a noteworthy CAGR during the forecast period, supported by rapid urbanization, a high-income population, and an expanding focus on digital health. Consumers in the UAE are increasingly turning to homecare and remote monitoring solutions, making portable and smart CPAP devices highly attractive. Moreover, the rise of medical tourism and the country’s modern healthcare infrastructure are boosting the availability and use of advanced sleep therapy equipment.

Egypt CPAP Devices Market Insight

The Egypt CPAP devices market is poised for moderate growth, driven by increased awareness campaigns and gradual improvements in healthcare access. Although the market is still in its early stages, growing diagnosis rates for sleep-related disorders and support from international health organizations are helping to drive CPAP device adoption. As affordability improves and more players enter the market with cost-effective solutions, Egypt is expected to emerge as a significant contributor to regional growth.

Middle East and Africa CPAP Devices Market Share

The Middle East and Africa CPAP Devices industry is primarily led by well-established companies, including:

• ResMed Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Fisher & Paykel Healthcare Limited (New Zealand)
• BMC Medical Co., Ltd. (China)
• Apex Medical Corp. (Taiwan)
• Löwenstein Medical GmbH & Co. KG (Germany)
• Drive DeVilbiss Healthcare LLC (U.S.)
• 3B Medical, Inc. (U.S.)
• Breas Medical AB (Sweden)
• Somnetics International, Inc. (U.S.)
• SLS Medical Technology (China)
• Resvent Medical Technology Co., Ltd. (China)
• Teijin Pharma Limited (Japan)
• Koike Medical Co., Ltd. (Japan)
• Nidek Medical India Pvt. Ltd. (India)
• Medtronic (Ireland)
• Cardinal Health, Inc. (U.S.)
• Smiths Medical, Inc. (U.K.)
• Fosun Pharma (China)
• Elmaslar Medikal Sistemleri (Turkey)

What are the Recent Developments in Middle East and Africa CPAP Devices Market?

• In May 2024, ResMed Inc., a global leader in sleep and respiratory care, partnered with leading South African healthcare distributors to expand access to its portable CPAP devices across urban and semi-urban areas. This strategic collaboration aims to address the growing demand for home-based sleep apnea treatment and increase awareness through targeted educational campaigns, highlighting ResMed’s commitment to improving sleep health outcomes in the region
• In March 2024, Philips Respironics launched a regional training and support initiative in the UAE to enhance clinical adoption of its advanced CPAP systems, including DreamStation 2 Auto CPAP. The program is designed to equip healthcare professionals with the latest tools and knowledge for effective sleep apnea management, supporting Philips’ efforts to boost CPAP therapy penetration and ensure better patient outcomes across the Middle East
• In February 2024, BMC Medical Co., Ltd., a China-based respiratory care provider, expanded its footprint in the Middle East through new distribution agreements in Egypt and Saudi Arabia. The company introduced a range of affordable and portable CPAP solutions tailored to local market needs, including devices with integrated humidifiers and mobile monitoring apps. This expansion reflects BMC’s strategy to cater to cost-sensitive segments while promoting home therapy adoption
• In January 2024, Löwenstein Medical, a German medical technology company, launched a regional support hub in South Africa to provide after-sales service and product training for its PrismaLINE CPAP systems. This move enhances customer engagement and operational support, reinforcing Löwenstein’s presence in the African market and its commitment to high-quality respiratory care delivery
• In December 2023, Fisher & Paykel Healthcare conducted a sleep wellness awareness campaign in partnership with private hospitals in Kenya and Nigeria. The initiative focused on early diagnosis of OSA and introduced the company’s range of CPAP devices equipped with advanced humidification technology. The campaign emphasizes Fisher & Paykel’s ongoing efforts to drive sleep disorder awareness and support accessible, comfortable therapy options across underserved regions

SKU-72895